LIR Life Sciences Corp. (CSE:SKNY)
Canada flag Canada · Delayed Price · Currency is CAD
0.2200
0.00 (0.00%)
Oct 6, 2026, 12:16 PM EST

LIR Life Sciences Balance Sheet

Millions CAD. Fiscal year is May - Apr.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024
Period Ending
Jul '26 Apr '26 Apr '25 Apr '24
Cash & Equivalents
0.20.60.120.2
Cash & Short-Term Investments
0.20.60.120.2
Cash Growth
7602.56%393.49%-38.01%-
Other Receivables
0.10.07-0.01
Receivables
0.10.07-0.01
Prepaid Expenses
0.010.17--
Total Current Assets
0.310.840.120.2
Total Assets
0.310.840.120.2

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024
Period Ending
Jul '26 Apr '26 Apr '25 Apr '24
Accounts Payable
0.220.110.20.04
Accrued Expenses
0.020.07--
Short-Term Debt
---0.19
Total Current Liabilities
0.240.180.20.23
Total Liabilities
0.240.180.20.23

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024
Period Ending
Jul '26 Apr '26 Apr '25 Apr '24
Common Stock
4.074.070.30
Retained Earnings
-5.34-4.35-0.45-0.03
Comprehensive Income & Other
1.340.940.07-
Shareholders' Equity
0.070.66-0.08-0.03
Total Liabilities & Equity
0.310.840.120.2

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024
Period Ending
Jul '26 Apr '26 Apr '25 Apr '24
Total Debt
---0.19
Net Cash (Debt)
0.20.60.120
Net Cash Growth
-393.49%147336.58%-
Net Cash Per Share
0.010.030.020.01
Filing Date Shares Outstanding
28.6728.6718.950.01
Total Common Shares Outstanding
28.6728.67190.01
Working Capital
0.070.66-0.08-0.03
Book Value Per Share
0.000.02-0.00-2.11
Tangible Book Value
0.070.66-0.08-0.03
Tangible Book Value Per Share
0.000.02-0.00-2.11